白血病髓外浸润相关微环境王慧石军

国际肿瘤学杂志››2014,Vol. 41››Issue (11): 851-854.doi:10.3760/cma.j.issn.1673-422X.2014.11.016

白血病髓外浸润相关微环境王慧石军

上海交通大学附属第六人民医院血液科

出版日期:2014-12-03发布日期:2015-01-20
通讯作者:石军， Email：shijun7@hotmail.com
基金资助:

国家自然科学基金（81170507）；上海市科委课题（13DZ2293702）

Microenvironment for leukemia extramedullary infiltration

Department of Hematology, Affiliated Sixth People′s Hospital of Shanghai Jiaotong University, Shanghai 200233, China

Online:2014-12-03Published:2015-01-20
Contact:Shi Jun, Email: shijun7@hotmail.com

摘要/Abstract

摘要：白血病细胞的髓外组织浸润是导致白血病患者复发、死亡的重要原因之一，越来越多的研究显示髓外微环境在白血病进展和复发中发挥重要作用。白血病髓外浸润的发生是多因素、多步骤相互作用的结果，涉及肝、脾、中枢神经系统、胸腺等各组织器官。

王慧, 石军. 白血病髓外浸润相关微环境王慧石军[J]. 国际肿瘤学杂志, 2014, 41(11): 851-854.

WANG Hui, SHI Jun. Microenvironment for leukemia extramedullary infiltration[J]. Journal of International Oncology, 2014, 41(11): 851-854.

［1］ Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 20012007［J］. Blood, 2012, 119(1):3443. ［2］ Kobayashi R, Tawa A, Hanada R, et al. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia［J］. Pediatr Blood Cancer, 2007, 48(4):393398. ［3］ Yang LL, Gan SL, Liu YF, et al. Clinical characteristics of CD56(+) patients with acute monocytic leukemia and their prognostic significance［J］. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2013, 21(3):596600. ［4］ Shimizu H, Saitoh T, Hatsumi N, et al. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia［J］. Leuk Res, 2013, 37(11):14771481. ［5］ Ge L, Ye F, Mao X, et al. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acutemyelogenous leukemia and acute lymphoblastic leukemia［J］.Biol Blood Marrow Transplant,2014, 20（7）： 10401047. ［6］ Jacamo R, Chen Y, Wang Z, et al. Reciprocal leukemiastroma VCAM1/VLA4dependent activation of NFkappaB mediates chemoresistance［J］. Blood, 2014, 123(17):26912702. ［7］ Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapyresistant human AML stem cells home to and engraft within the bonemarrow endosteal region［J］. Nat Biotechnol, 2007, 25(11):13151321. ［8］ Saito Y, Uchida N, Tanaka S, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML［J］. Nat Biotechnol, 2010, 28(3):275280. ［9］ Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children′s Oncology Group study［J］. Blood, 2008, 111(12):54775485. ［10］ Kato I, Niwa A, Heike T, et al. Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF1/CXCR4 axis［J］. PLoS One, 2011, 6(11):e27042. ［11］马玉花，邹亚伟. 白血病肝损伤的研究进展［J］. 中国小儿血液与肿瘤杂志，2013, 18（2）:9396. ［12］ Schemionek M, Spieker T, Kerstiens L, et al. Leukemic spleen cells are more potent than bone marrowderived cells in a transgenic mouse model of CML［J］. Leukemia, 2012, 26(5):10301037. ［13］ Sengupta A, Arnett J, Dunn S, et al. Rac2 GTPase deficiency depletes BCRABL+ leukemic stem cells and progenitors in vivo［J］. Blood, 2010, 116(1):8184. ［14］ Shaked Y, Cervi D, Neuman M, et al. The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells［J］. Blood, 2005, 105(11):45004507. ［15］ Feng SR, Chen ZX, Cen JN, et al. Disruption of blood brainbarrier by leukemic cells in central nervous system leukemia［J］. Zhonghua Xue Ye Xue Za Zhi, 2011, 32(5):289293. ［16］ Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia［J］. Lancet Oncol, 2008, 9(3):257268. ［17］ Feng S, Cen J, Huang Y, et al. Matrix metalloproteinase2 and 9 secreted by leukemic cells increase the permeability of bloodbrain barrier by disrupting tight junction proteins［J］. PLoS One, 2011, 6(8):e20599. ［18］ Raanani P, Shpilberg O, BenBassat I. Extramedullary disease and targeted therapies for hematological malignanciesis the association real?［J］. Ann Oncol, 2007, 18(1):712. ［19］ Tsukamoto S, Ota S, Ohwada C, et al. Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation［J］. Leuk Res Rep, 2013, 2(2):6769.

[1]	滕远, 李莉娟, 张连生.MCL-1及其抑制剂在血液恶性肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 119-122.
[2]	王军, 贾秀红.TGF-β/Smad信号通路与急性白血病[J]. 国际肿瘤学杂志, 2023, 50(8): 498-502.
[3]	王婷, 李文倩, 解友邦.低氧与急性髓系白血病细胞氧感受通路的相关性[J]. 国际肿瘤学杂志, 2023, 50(8): 503-507.
[4]	邢明泉, 葛洪峰, 张丽侠, 韩浩, 吴维霞.疑似免疫性血小板减少症的侵袭性自然杀伤细胞白血病1例[J]. 国际肿瘤学杂志, 2023, 50(5): 318-320.
[5]	张婷, 贾秀红.细胞焦亡在白血病中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(11): 696-700.
[6]	陆佳玲, 黄慧娟, 刘丹, 陈妍心, 马骁, 吴德沛.博纳吐单抗治疗急性B淋巴细胞白血病的疗效和安全性[J]. 国际肿瘤学杂志, 2022, 49(8): 494-498.
[7]	周欣宇, 贾秀红.铁死亡在白血病治疗中的研究进展[J]. 国际肿瘤学杂志, 2022, 49(12): 759-762.
[8]	陈曦, 母丹, 严钦, 刘文君.骨髓微环境与白血病细胞分化[J]. 国际肿瘤学杂志, 2021, 48(3): 189-192.
[9]	李伟强, 吴洋, 万崇华, 谭健烽, 何争春, 孟琼.基于分布法的癌症患者生命质量测定量表体系之白血病量表的最小临床重要性差值制定[J]. 国际肿瘤学杂志, 2021, 48(10): 577-582.
[10]	李转丽, 张君玲, 石亚军, 白海.伴DDX41体细胞突变及TP53双突变急性髓系白血病一例[J]. 国际肿瘤学杂志, 2021, 48(10): 638-640.
[11]	许蕾, 戴婧, 张倩, 张文丽, 李晋萌, 张红宇.93例成人急性淋巴细胞白血病的临床分析[J]. 国际肿瘤学杂志, 2020, 47(9): 535-541.
[12]	孙王男, 都鹏超, 齐福, 王文凤, 姜国胜.miR-5581-5p/TRIM22在急性早幼粒细胞白血病细胞分化中的作用[J]. 国际肿瘤学杂志, 2020, 47(3): 129-134.
[13]	洪梨, 王玉, 张琦, 吕成芳.尼洛替尼一线治疗慢性髓系白血病的进展[J]. 国际肿瘤学杂志, 2020, 47(1): 56-59.
[14]	雷林，吉勇，尚庆刚，彭绩，任骅.深圳市2001—2015年白血病流行特征和时间趋势[J]. 国际肿瘤学杂志, 2019, 46(7): 415-419.
[15]	斯赛女, 王华英, 俞万钧, 李纪鹏. 白血病抑制因子在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2019, 46(10): 605-608.